INFLUENCE OF N-ACETYLCYSTEINE AND LOSARTAN ON MODULATION OF CYTOPROTECTIVE AUTOPHAGY IN MYOCARDIUM OF RATS WITH EXPERIMENTAL TYPE 1 DIABETES MELLITUS (FOR ELECTRONIC MICROSCOPY EXPLANATION)
Abstract
The purpose of the research work is to study the features of the autophagy in case of the streptozotocin- induced type 1 diabetes mellitus and its changes in the application of different pharmacological schemes, such as N-acety I cysteine (NAC) and losartan (LOS).
Materials and methods. Type 1 diabetes mellitus (DM1) was induced by intraperitoneal injection of streptozotocin (STZ) at the dose of 50 mg/kg. Animals were randomly divided into 5 groups: Control (intact rats); DM1 (untreated diabetic control rats supplemented with 0.9% normal saline per os) ' NAC (diabetic rats treated with N-acetylcysteine at a dose 1.5g/kg per os); LOS (diabetic rats treated with losartan at a dose 20mg/kg per os as reference drug); NAC+LOS ( diabetic rats treated with combination of NAC and LOS per os). The portions of the left ventricle myocardium were the material of the electromicroscopical research studies.
Results. Metabolical type structural changes (changes in mitochondria of endoplasmatic reticulum, lysosome and autophagosome) were found out in the cardiac cells of rats with the STZ DM1. In the NAC experimental group, ultrastructural features of upregulation of the protein secretion in the cardiac cells were found out and directed against newly created myofibrilla in the setting of the hypertrophy of the metabolic type cell organelle; the autophagy processes started to work. In the LOS experimental group, major contraction damages of cardiomyocytes were found out along with decreasing number of autophagosomes: disorganization of mitochondria, anastalsis of myofibrilla and its localized lysis, albuminous degeneration, localized fractional necrosis of cardiomyocytes’ cytoplasm. In the NAC+LOS experimental group, the number of the autophagosome also considerably decreased; the cardiomyocytes’ burned-out changes and disruption of microcirculation were found out.
Summary. Due to the data of the electromicroscopical research study, NAC was found out as more effective restitution of the autophagy cytoprotective system, it was caused by its modulating action on oxidative stressautophagy target that can become a new treatment strategy in searching of selective cardioprotective drugs for the patients with diabetic cardiomyopathy.
References
Mei, Y, Thompson, M. D., Cohen, R. A., Tong, X.Y. (2015). Autophagy and oxidative stress in cardiovascular diseases. Biochimica et Biophysica Acta 1852, 2015, 243—251. Retrieved from: http://dx.doi.org/ 10.1016/j. b badis. 2014.05.005
Godar, R.J., Ma, X., Liu, H, Murphy, J.T., Weinheimer, C.J., Kovacs, A. et al. (2015). Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to іschemia/repefusion injury. Autophagy, 2015; 11(9), 1537—1560.
Li, E, Lang, F, Zhang, H, Xu, L., Wang, Y, Hao, E. (2016). Role of TFEB mediated autophagy, oxidative stress, inflammation, and cell death in endotoxin induced myocardial toxicity of young and aged mice. Oxidative Medicine and Cellular Longevity, 2016. Retrieved from: http:// dx. doi. org/10.1155/2016/5380319
McLendona, P.M., Fergusonb, B.S., Osinskaa, H, Bhuiyana, Sh., Jamesa, J., McKinsey, T.A. et al. (2014). Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy. PNAS, 111(48), E5178-E5186. Retrieved from: www.pnas.org/cgi/doi/10.1073/ pnas.1415589111
McCormick, J., Suleman, N., Scarabelli, T.M., Knight, R.A., Latchman, D.S., Stephanou, A. et al. (2012). STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. J. Cell. Mol. Med., 16(2), 386-393.
Li, L., Xuebo, L., Jianfeng, X., Liqing, W., Jun, R., Junbo, G. et al. (2016). Mas receptor mediates cardioprotection of angiotensin - (1-7) against Angiotensin Il-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress. J. Cell. Mol. Med., 20 (1), 48-57.
Haar, L., Ren, X, Liu, Y, Koch, S.E., Goines, J., Tranter, M. et al. (2014). Acute consumption of a high-fat diet prior to ischemia-reperfusion results in cardioprotection through NFkB-dependent regulation of autophagic pathways. Am J Physiol Heart Circ Physiol, 307, H1705— H1713.
Adams, B., Mapanga, R. F., Essop, M.F. (2015). Partial inhibition of the ubiquitin—proteasome system ameliorates cardiac dysfunction following ischemia—reperfusion in the presence of high glucose. Cardiovasc Diabetol, 14, 94- 109.
Zhang, L., Ding, W., Wang, Zh., Tang, M., Wang, F, Li, Y. et al. (2016). Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. JTranslMed, 14, 109-121.
Zhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Wang, L. et al. (2013). Hemeoxygenase-1 prevents cardiac dysfunction in streptozotocin- diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS ONE, %(9), e75927. Retrieved from: http:// doi: 10.13 71/journal.pone. 0075927
Zhang, M., Zhang, L., Hu, J., Jie, L., Tingting, W., Yu, D. et al. (2016). MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. Diabetologia. -doi: 10.1007/s00125016-4070-9. Retrieved from: http://link.springer.eom/article/10.1007%2Fs00125-016- 4070-9
Gao, H, Hou, F, Dong, R., Wang, Z., Zhao, C, Tang, W., Wu, Y. (2016). Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy. Cardiovasc Ther, 2016. doi: 10.1111/1755-5922.12206. Retrieved from: http:// www.ncbi.nlm.nih.gov/pubmed/27333569
Li, W., Li, X., Wang, B., Chen, Y, Xiao, A., Zeng, D. et al. (2016). ZLN005 protects cardiomyocytes against high glucose-induced cytotoxicity by promoting SIRT1 expression and autophagy. Exp Cell Res, 345(1), 25-36. doi: 10.1016/j.yexcr.2016.05.012. Retrieved from: http:// www. nebi. nlm. nih.gov/pubmed/2 7208585
Turan, В., Tuncay, E., Vassort, G. (2012). Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr, 44(2), 281-96. doi: 10.1007/sl0863-012-9429-0. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/22437738
Xu, J., Qin, X., Cai, X., Yang, L. , Xing, Y, Li, J. et al. (2015). Mitochondrial JNK activation triggers autophagy and apoptosis and aggravates myocardial injury following ischemia/reperfusion. Biochimica et Biophysica Acta 1852, 2015, 262—270. Retrieved from:: http:// dx. doi. org/10.1016/j. bbadis. 2014.05.012
Han, Zh., Cao, J., Song, D., Tian, L., Chen, K, Wang, Y. et al.
(2014). Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia/reperfusion injury in normal mice, but not diabetic mice. PLoS ONE, 9(1), e86838.
doi: 10.1371/journal.pone. 0086838
Danrui, C, Xiufang, X., Yongchao, Zh. (2016). Cullin-RING ligases in regulation of autophagy. Cell Div, 11 (8). DOI 10.1186/sl3008- 016-0022-5
Gottlieb, R.A., Mentzer, RM. (2013). Autophagy: an affair of the heart. Heart Fail Rev., 18, 575-584.
Wang, S., Wang, C, Yan, F. et al. (2017). N-acetylcysteine attenuates diabetic myocardial ischemia reperfusion injury through inhibiting excessive autophagy. Mediators of Inflammation, 2017, Article ID 9257291.
Sytnyk, I.M., Khaitovych, M.V., Chernovol, N.P. (2016). VplyvN- atsetyltsysteinu ta lozartanu na ranni elektrokardiohraflchni zminy и shchuriv iz streptozototsynovym tsukrovym diabetom 1 typu. Ukrainskyi naukovo-medychnyi molodizhnyi zhumal, 3 (46), 5-11.
Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes. (2010). Official Journal of the European Communities, 276, 33—79.
Animal Models of Diabetic Complications Consortium (AMDCC) Protocols. (2003). Low-Dose Streptozotocin Induction Protocol (Mouse), The University of Michigan Medical Center.
Karupu, V.Ya. (1984). Elektronnaia mykroskopyia. Kyev: Vyshcha shkola.
Hayat, M.A. (2000). Principles and techniques of electron microscopy: biological applications. Cambridge: Cambridge University Press.
Moyzis, A.G., Sadoshima, J., Gustafsson, E.B. (2015). Mending a broken heart: the role of mitophagy in cardioprotection. Am J Physiol Heart Circ Physiol, 308, H183-H192.
Qiulin, X., Xixian, L., Yongkang, L., Liang, Sh., Jingwen, Zh., Shiping, C. et al. (2015). Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/ reperfusion. British Journal of Pharmacology, 172, 3072—3085.
Krotova, Yu.N., Khloponyn, D.P., Khloponyn, P.A., Arkhypova, T.V. (2012). Analyz kardyoprotektornoho vlyianyia nebyvolola na ultrastrukturu myokarda pry reheneratorno-plastycheskoi serdechnoi nedostatochnosty и krys. Byomedytsyna, 1, 86-92.
Meng-Qing, M., Bisharad, A.T., Xian-He, L. (2015). A 6 hour therapeutic window, optimal for interventions targeting AMPK synergism and apoptosis antagonism, for cardioprotection against myocardial ischemic injury: an experimental study on rats. Am J Cardiovasc Dis, 5(1), 63-71.
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 
ISSN 
